Filter system and method

Information

  • Patent Grant
  • 9622859
  • Patent Number
    9,622,859
  • Date Filed
    Friday, January 23, 2015
    9 years ago
  • Date Issued
    Tuesday, April 18, 2017
    7 years ago
Abstract
A filter system, comprising an elongate filter body defining a lumen and having a proximal end and a distal end. A valve can be provided defining a lumen and having a reversibly sealable opening for unidirectional flow of a fluid through the lumen. The valve can be adjoined proximal the distal end of the elongate filter body, wherein the elongate filter body filters the unidirectional flow of the fluid passing through the lumen of the valve and the lumen of the elongate filter body.
Description
FIELD OF THE INVENTION

The present invention relates generally to apparatus, systems, and methods for use in a lumen; and more particularly to a valve and filter apparatus, system, and method for use in the vasculature system.


BACKGROUND OF THE INVENTION

Cardiac valves can become damaged and/or diseased for a variety of reasons. Damaged and/or diseased cardiac valves are grouped according to which valve or valves are involved, and the amount of blood flow that is disrupted by the damaged and/or diseased valve. The most common cardiac valve diseases occur in the mitral and aortic valves. Diseases of the tricuspid and pulmonary valves are fairly rare.


The aortic valve regulates the blood flow from the heart's left ventricle into the aorta. The aorta is the main artery that supplies oxygenated blood to the body. As a result, diseases of the aortic valve can have a significant impact on an individual's health. Examples of such diseases include aortic regurgitation and aortic stenosis.


Aortic regurgitation is also called aortic insufficiency or aortic incompetence. It is a condition in which blood flows backward from a widened or weakened aortic valve into the left ventricle of the heart. In its most serious form, aortic regurgitation is caused by an infection that leaves holes in the valve leaflets. Symptoms of aortic regurgitation may not appear for years. When symptoms do appear, it is because the left ventricle must work harder relative to an uncompromised aortic valve to make up for the backflow of blood. The ventricle eventually gets larger and fluid backs up.


Aortic stenosis is a narrowing or blockage of the aortic valve. Aortic stenosis occurs when the valve leaflets of the aorta become coated with deposits. The deposits change the shape of the leaflets and reduce blood flow through the valve. Again, the left ventricle has to work harder relative to an uncompromised aortic valve to make up for the reduced blood flow. Over time, the extra work can weaken the heart muscle.





BRIEF DESCRIPTION OF THE DRAWINGS


FIGS. 1A-1B illustrate an embodiment of a filter system.



FIGS. 2A-2B illustrate another embodiment of a filter system.



FIGS. 3A-3C illustrate another embodiment of the filter system.



FIGS. 4A-4D illustrate another embodiment of the filter system.





DETAILED DESCRIPTION

Embodiments of the present invention are directed to a filter system and method for temporary placement and use in a lumen. Embodiments of the present invention are also directed to augmenting cardiac valve function while filtering fluid moving within the lumen. For example, the filter system and method can be used to temporarily replace, or augment, an incompetent valve in a body lumen and/or can be used as a temporary valve during a procedure to repair or to replace an incompetent valve with a prosthetic valve.


Embodiments of the filter system can further include a sheath that can be used to help position the filter system within a body lumen, such as an artery or a vein, through minimally-invasive techniques. In further embodiments, additional structures can be used in conjunction with the filter system. For example, catheters having tissue shearing capability, stent delivery capability, and prosthetic valve delivery capability can also be used in conjunction with the filter system to aid in the replacement of a diseased native valve with a prosthetic valve. In an additional embodiment, the sheath can include a deployment rod to extend and retract the cardiac valve and filter. After replacement or repair of a native valve, the filter system can be refracted into the lumen of the sheath.


The Figures herein follow a numbering convention in which the first digit or digits correspond to the drawing Figure number and the remaining digits identify an element or component in the drawing. Similar elements or components between different Figures may be identified by the use of similar digits. For example, 110 may reference element “10” in FIG. 1, and a similar element may be referenced as 210 in FIG. 2. As will be appreciated, elements shown in the various embodiments herein can be added, exchanged, and/or eliminated so as to provide any number of additional embodiments of the filter system. In addition, the elements shown in the various embodiments are not necessarily to scale.


Various embodiments of the invention are illustrated in the figures. Generally, the filter system can be used to provide a temporary valve for replacement or repair of a diseased and/or damaged valve. Other embodiments can be used to provide a temporary valve and filter during a procedure to repair a diseased or damaged valve or replace a diseased and/or damaged valve with a permanent valve. For example, the placement of the valve and filter apparatus within a body lumen (e.g., within the aorta, adjacent the aortic valve), can help to provide for a temporary valve and filter to regulate fluid flow and filter particulate matter from fluid flowing through the aorta during transluminal cardiac valve repair and/or replacement.



FIGS. 1A and 1B illustrate one embodiment of a filter system 100 shown in perspective view. Filter system 100 includes an elongate filter body 102 including an expandable filter region 150 and a valve 104. FIGS. 1A and 1B provide a perspective illustration of the valve 104 of filter system 100 in an open configuration (FIG. 1A) and a closed configuration (FIG. 1B). In addition, the perspectives illustrated in FIGS. 1A and 1B show the filter system 100 in an expanded configuration, as will be discussed herein.


In the present embodiments, the elongate filter body 102 defines a lumen 106 extending from a proximal end 108 towards a distal end 110. In one embodiment, the lumen 106 can be concentric with an elongate axis of the elongate filter body 102. The valve 104 also defines a lumen 112. In one example, the valve 104 can be adjoined proximal the distal end 110 of the elongate filter body, where the lumen 112 of the valve 104 and the lumen 106 of the elongate filter body 102 can form a single lumen 114. In other words, the lumens 106 and 112 can be contiguous so as to form the single lumen 114. Other configurations are also possible.


In the various embodiments, filter system 100 allows for both unidirectional flow of fluid and filtering of the fluid passing through the lumens 106 and 112. With respect to providing unidirectional flow of the fluid through lumens 106 and 112, the valve 104 includes a reversibly sealable opening 116. In one embodiment, the reversibly sealable opening 116 can be formed by one or more valve leaflets 118. In forming the reversibly sealable opening 116, the valve leaflets 118 are configured to move between an open configuration (e.g., FIG. 1A, allowing fluid to flow in a first direction 193 through the lumens 106 and 112) and a closed configuration (e.g., FIG. 1B, preventing fluid from flowing in a second direction 197 opposite the first direction 193).


The valve 104 can include any number of configurations so as to define the lumen 112 and provide the reversibly sealable opening 116 for unidirectional flow of the fluid through the lumen 112. For example, the valve 104 can include a frame 120 that supports a cover 122. In the various embodiments, the cover 122 defines the reversibly sealable valve leaflets 118 that provide for the unidirectional flow of a fluid through the lumen 112 of the valve 104.


Examples of a valve suitable for use as valve 104 is illustrated in U.S. patent application Ser. No. 10/741,995, entitled “Venous Valve Apparatus, System, and Method”, and in U.S. patent application Ser. No. 11/052,655, entitled “Venous Valve Apparatus, System, and Method”, both of which are hereby incorporated by reference in their entirety. As illustrated, frame 120 includes a variety of structural configurations. Generally, the frame 120 has a curved structural configuration, as will be discussed herein. For example, the frame 120 can include a first elliptical member 124 and a second elliptical member 126, as illustrated in FIGS. 1A and 1B.


In the various embodiments, the first elliptical member 124 and the second elliptical member 126 meet at a first region 128 and a second region 130, where the first region 128 and the second region 130 are opposite each other across axis 132. The first region 128 and the second region 130 can be located at any number of locations along the first elliptical member 124 and the second elliptical member 126. For example, the first region 128 and the second region 130 can be at or near a minor axis of the first elliptical member 124 and the second elliptical member 126. In an additional embodiment, the first region 128 and the second region 130 can be positioned away from the minor axis of the first elliptical member 124 and the second elliptical member 126.


While the term elliptical member is used herein, other shapes are possible for the structural members that help to form a valve according to the embodiments herein. For example, the frame 120 can include circular members that meet at the first region 128 and the second region 130. Other shapes besides elliptical and circular are also possible.


The first elliptical member 124 and the second elliptical member 126 meet at the first region 128 and the second region 130 at an angle 134. In one embodiment, the size of angle 134 when the valve 104 is expanded can be selected based upon the type of body lumen and the body lumen size in which the valve 104 is to be placed. Additional factors include, but are not limited to, a longitudinal length 136 and a width 138 of the valve 104. These factors, along with others discussed herein, can be used to provide the angle 134 that is sufficient to ensure that the first elliptical member 124 and the second elliptical member 126 have an appropriate expansion force against an inner wall of the body lumen in which the valve 104 is being placed.


The valve 104 also includes a flexible joint at and/or around axis 132 that allows the valve 104 to accommodate changes in body lumen size (e.g., diameter of the body lumen) by increasing or decreasing angle 134 when the valve 104 is expanded. In addition, the frame 120 also has the ability to flex, as discussed herein, to allow for the distance between the first region 128 and the second region 130 to increase or decrease, thereby further accommodating changes in the body lumen size (e.g., diameter of the body lumen). The frame 120 also provides sufficient contact and expansion force with the surface of a body lumen wall to encourage seating of the valve 104 and to prevent retrograde flow, i.e., second direction 197, within the body lumen.


The frame 120 can be formed from a biocompatible metal, metal alloy, polymeric material, or combinations thereof, which allow the frame 120 to move radially between the collapsed and expanded state, as discussed herein. To accomplish this, the biocompatible metal, metal alloy, or polymeric material should exhibit a low elastic modulus and a high yield stress for large elastic strains that can recover from elastic deformations. Examples of suitable materials include, but are not limited to, medical grade stainless steel (e.g., 316L), titanium, tantalum, platinum alloys, niobium alloys, cobalt alloys, alginate, or combinations thereof. In an additional embodiment, the frame 120 may be formed from a shape-memory material. Examples of a suitable shape-memory material include, but are not limited to, alloys of nickel and titanium in specific proportions known in the art as nitinol. Other materials are also possible.


The valve 104 can further include one or more radiopaque markers 152 (e.g., tabs, sleeves, welds). For example, one or more portions of the frame 120 can be formed from a radiopaque material. Radiopaque markers can be attached to and/or coated onto one or more locations along the frame 120. Examples of radiopaque materials include, but are not limited to, gold, tantalum, and platinum. The position of the one or more radiopaque markers can be selected so as to provide information on the position, location and orientation of the valve 104 during its implantation.


The valve 104 further includes the cover 122. In the various embodiments, the cover 122 forms the valve leaflets 118 joined to valve frame 120. The valve leaflets 118 can deflect between a closed configuration (FIG. 1B) in which retrograde fluid flow through the valve 104 is restricted, and an open configuration (FIG. 1A) in which antegrade fluid flow through the valve 104 is permitted. In one embodiment, valve leaflets 118 of the valve are configured to open and close in response to the fluid motion and/or pressure differential across the valve leaflets 118.


The example of valve 104 shown in FIGS. 1A and 1B provide embodiments in which the surfaces defining the reversibly sealable opening 116 include a first leaflet 140 and a second leaflet 142 coupled to the valve frame 120 to provide a two-leaflet configuration (i.e., a bicuspid valve) for valve 104. Although the embodiments illustrated in FIGS. 1A-1B of the present invention show and describe a two-leaflet configuration for valve 104, designs employing a different number of valve leaflets (e.g., tricuspid valve) are possible and considered within the scope of the embodiments.


The valve leaflets 118 can have a variety of sizes and shapes. For example, each of the valve leaflets 118 (e.g., first leaflet 140 and second leaflet 142) can have a similar size and shape. In an additional example, each of the valve leaflets 118 need not have valve leaflets 118 that are of a similar size and shape (i.e., the valve leaflets can have a different size and shape).


Valve frame 120 can include an open frame construction (i.e., valve frame 120 defines an opening) through which valve leaflets 118 can radially-collapse and radially-expand. The valve leaflets 118 can be provided over the open frame construction of the valve frame 120 to direct fluid flow through reversibly sealable opening 116 under specific fluid flow conditions. In one embodiment, the material of the valve leaflets 118 coupled to the valve frame 120 can be sufficiently thin and pliable so as to permit radially-collapsing of the valve leaflets 118 for delivery by catheter to a location within a body lumen.


In one embodiment, each of the valve leaflets 118 includes sufficient excess material spanning valve frame 120 such that fluid pressure (e.g., antegrade flow) acting on the valve leaflets 118 forces the valve 104 into an open configuration (FIG. 1A). Valve leaflets 118 can further include arcuate edges 144 and 146, as shown in FIG. 1A, that are positioned adjacent each other along a substantially catenary curve between the first region 128 and the second region 130 in the closed configuration (FIG. 1B) of valve 104. Similarly, arcuate edges 144 and 146 can help to define lumen 112 when the valve 104 is in the open configuration (FIG. 1A).


In an additional embodiment, in the open configuration the sufficient excess material spanning the valve frame 120 can allow the valve leaflets 118 to take on a semi-tubular structure, as shown in FIG. 1A, when fluid pressure opens the valve 104. In an additional embodiment, arcuate edge 144 and 146 of valve 100 can open to approximately the full inner diameter of body lumen.


Each of the valve leaflets 118 can further include a curve imparted thereto so as to provide a concave structure 148 to the leaflet 118. The concave structure 148 allows the valve leaflets 118 to better collect retrograde fluid flow to urge valve leaflets 118 towards the closed configuration. For example, as retrograde flow begins, the valve leaflets 118 respond by moving towards the center of valve 104. As the valve leaflets 118 approach the center of the device the valve leaflets 118 make sufficient contact to effectively close the reversibly sealable opening 116 of valve 104 and thereby restrict retrograde fluid flow.


In an additional embodiment, the valve leaflets 118 can include one or more support structures. For example, the valve leaflets 118 can include one or more support ribs having a predetermined shape. In one embodiment, the predetermined shape of the support ribs can include a curved bias so as to provide the valve leaflets 118 with a curved configuration. Support ribs can be constructed of a flexible material and have dimensions (e.g., thickness, width and length) and cross-sectional shape that allows the support ribs to be flexible when valve leaflets 118 are urged into an open position, and stiff when the valve leaflets 118 are urged into a closed position upon experiencing sufficient back flow pressure from the direction downstream from the valve. In an additional embodiment, support ribs can also be attached to valve frame 120 so as to impart a spring bias to the valve leaflets in either the open or the closed configuration.


The valve leaflets 118 can be constructed of a fluid-impermeable biocompatible material that can be either synthetic or biologic. Possible synthetic materials include, but are not limited to, expanded polytetrafluoroethylene (ePTFE), polytetrafluoroethylene (PTFE), polystyrene-polyisobutylene-polystyrene, polyurethane, segmented poly(carbonate-urethane), Dacron, polyethlylene (PE), polyethylene terephthalate (PET), silk, urethane, Rayon, Silicone, or the like. Possible biologic materials include, but are not limited to allogeneic or xenograft material. These include explanted veins and decellularized basement membrane materials, such as small intestine submucosa (SIS) or umbilical vein.


Valve leaflets 118 can be coupled to the various embodiments of valve frame 120, as described herein, in any number of ways. For example, a variety of fasteners can be used to couple the material of the valve leaflets 118 to the valve frame 120. Fasteners can include, but are not limited to, biocompatible staples, glues, and sutures. In one embodiment, the material of the valve leaflets 118 can be wrapped at least partially around the valve frame 120 and coupled using the fastener. In an additional embodiment, valve leaflets 118 can be coupled to the various embodiments of valve frame 120 through the use of heat sealing, solvent bonding, adhesive bonding, or welding the valve leaflets 118 to either a portion of the valve leaflet 118 (i.e., itself) and/or the valve frame 120. Valve leaflets 118 can also be attached to valve frame 120 according to the methods described in U.S. Patent Application Publication US 2002/0178570 to Sogard et al., which is hereby incorporated by reference in its entirety.


In an alternative embodiment, the valve 104 can include three leaflets, with the various frames and covering configurations as described herein. Further, valve 104 can be configured to extend proximally and distally in a curvilinear manner to accommodate the coronary ostia and the diseased valve. For example, leaflets can extend past the coronary ostia in the central portion of the leaflets, and extend to accommodate the attachment points of the diseased valve by incorporating a tri-lobar saddle shaped configuration. In one embodiment, the valve 104 can include a configuration that allows the valve 104 to be place functionally distal to the coronary ostia for proper coronary perfusion, while maintaining sufficient clearance for the diseased valve and the repair or replacement of the diseased valve to be performed. Examples of a three leaflet valve suitable for use as valve 104 are illustrated in U.S. patent application Ser. No. 11/107,162, entitled “Valve Apparatus, System and Method”, and U.S. patent application Ser. No. 10/933,088, entitled “Cardiac Valve, System, and Method”, which is hereby incorporated by reference in its entirety.


In various embodiments, a portion of the elongate filter body 102 can include an expandable filter region 150 to filter the unidirectional flow of the fluid moving through the valve 104. As used herein, filtering of fluid can be accomplished through use of the expandable filter region 150 by trapping and/or inhibiting the passage of particular matter released into and/or present in the fluid moving through the valve 104. Trapped particulate matter can then be removed with the filter system 100 through the lumen 106.


As illustrated in FIGS. 1A-1B, the valve 104 can be adjoined proximal the distal end 110 of the elongate filter body 102. For example, the frame 120 of the valve 104 can be coupled to the expandable filter region 150 proximal the distal end 110 of the elongate filter body 102. Methods of coupling the frame 120 to the expandable filter region 150 of the elongate filter body 102 can be as described herein for coupling the valve leaflets 118 to the frame 120.


As will be illustrated herein, the expandable filter region 150 can move between a first configuration (e.g., a compressed state, shown in FIG. 3A) and a second configuration (e.g., an expanded state, shown in FIGS. 1A-1B and FIGS. 2A-2B). In one embodiment, the expandable filter region 150 can expand from the first configuration to the second configuration due to force imparted by the frame 120 as it expands. In addition, the expandable filter region 150 can expand from the first configuration to the second configuration by a combination of force imparted by the frame 120 as it expands and under pressure of the unidirectional flow of the fluid. Additionally, the force imparted by the frame when the valve is in the open configuration can help to maintain the expandable filter region expanded when under retrograde fluid flow, such as when the valve is in a closed configuration. In an additional embodiment, the expandable filter region 150 can be configured to radially self-expand when released from a compressed state.


In the various embodiments, the expandable filter region 150 in its deployed state can fill the cross-section area of the lumen in which the expandable filter region 150 and valve 104 are deployed. In addition, filter region 150 in its deployed state can apply sufficient pressure to the inner wall of the lumen to reduce the volume of fluid (e.g., blood) that may pass between the filter region 150 and the surface of the lumen wall. In one embodiment, the valve frame 120 can be used at least in part to apply the sufficient pressure to the inner wall of the body lumen. As will be appreciated, the area and shape defined by the expandable filter region 150 (e.g., the diameter of the expandable filter region) in its deployed state can be dependent upon the location in which the apparatus is intended to be used.


Examples of expandable filter region 150 include those having a woven, braided and/or a knit configuration as the same will be known and understood by one of ordinary skill in the art. Alternatively, the expandable filter regions 150 can be formed of a material having pores formed therein or imparted thereto. In the various embodiments, the expandable filter regions 150 can be formed of a number of materials. Materials can include polymers, such as ePTFE, PTFE, polystyrene-polyisobutylene-polystyrene, polyurethane, segmented poly(carbonate-urethane), Dacron, PE, PET, silk, urethane, Rayon, Silicone, polyamid, mixtures, and block co-polymers thereof.


In one embodiment, expandable filter region 150 can be configured to reduce passage of potentially injurious emboli to arteries feeding the brain, heart, kidneys, and other tissues and organs. For example, expandable filter region 150 can help to reduce or prevent passage of emboli greater than about 5 to 1000 micrometers in cross-sectional size. Expandable filter region 150 may also prevent passage of emboli larger than 50 to 200 micrometers in cross-sectional size. Multiple regions or layers of expandable filter region 150 may be incorporated to more efficiently filter emboli, such as a 200 micrometer portion of the expandable filter region 150 to capture larger particles and a 75 micrometer portion of the expandable filter region 150 to capture smaller particles.


Additional examples of the expandable filter region 150 include the radially self-expanding configurations formed from temperature-sensitive memory alloy which changes shape at a designated temperature or temperature range. Examples of such materials include, but are not limited to, nitinol and nitinol-type metal alloys. Alternatively, self-expanding configurations for the expandable filter region 150 include those having a spring-bias imparted into the members forming the filter region 150. The expandable filter region 150 can have a woven, braided and/or a knit configuration that can also impart a self-expanding aspect to the expandable filter region 150.


In an additional embodiment, the filter region 150 can further include radiopaque markers 152. For example, radiopaque markers (e.g., attached or coated) can be used to mark the location of the valve 104 and/or the expandable filter region 150. Other portions of filter system 100 can also be marked with radiopaque markers as necessary to allow for visualization of the location and position of parts of the filter system 100.


The elongate filter body 102 can further include a fluid tight plug 154 positioned within the lumen 106 of the elongate filter body 102. In one embodiment, the fluid tight plug 154 can be positioned proximal the expandable filter region 150 so as to occlude the lumen 106, thereby directing the unidirectional flow of the fluid from the lumen 106 through the expandable filter region 150.


The fluid tight plug 154 can have a variety of shapes and configurations. For example, a first end 155 and a second end 157 of the fluid tight plug 154 can include a flat planar surface. In an alternative embodiment, the first end 155 of the fluid tight plug can include a conical configuration, as shown in FIGS. 1A and 1B. Other shapes and configurations for the fluid tight plug 154 are also possible.



FIGS. 2A and 2B illustrate an additional embodiment of a filter system 200. FIGS. 2A and 2B provide a perspective illustration of the filter system 200 that includes both the elongate filter body 202, as described herein, and the valve 204. In the present example, however, the valve 204 includes a frame 220 and a cover 222, including valve leaflets 240 and 242 (shown in FIG. 2A), having a different configuration as compared to the valve 104 described above in FIGS. 1A and 1B. One example of valve 204 is illustrated in U.S. patent application Ser. No. 10/741,992, entitled “Venous Valve Apparatus, System, and Method”, which is hereby incorporated by reference in its entirety.


The frame 220 of valve 204 includes an outer surface 256 and an inner surface 258 opposite the outer surface 256. The inner surface 258 defines the lumen 212 of the valve 204 for passing fluid therethrough. The frame 220 also includes a first end 262 and a second end 260. In one embodiment, the cover 222 can be located over at least the outer surface 256 of the frame 220. For example, the cover 222 can extend around a perimeter of the frame 220 so as to completely cover the outer surface 256 of the frame 220. In other words, the cover 222 extends over the outer surface of the frame 220 so that there are no exposed portions of the outer surface 256 of the frame 220. In an additional embodiment, the cover 222 can also be located over at least the inner surface 258 of the frame 220. A further embodiment includes the cover 222 located over at least the outer surface 256 and the inner surface 258.


In one embodiment, the frame 220 can include an open frame configuration that includes a first vertex 263 and a second vertex 264 relative the second end 260 of the frame 220. Frame 220 can further include a first valley 266 and a second valley 268 adjacent the second end 260 relative the first vertex 263 and the second vertex 264. As illustrated in FIGS. 2A and 2B, the first vertex 263 and the second vertex 264 can be positioned opposite each other along a common axis 270 (shown in FIG. 2B). FIGS. 2A and 2B also illustrate that the first valley 266 and the second valley 268 can be positioned opposite each other and perpendicular to axis 270. Other relative positions for the first and second vertex 263 and 264, and the first and second valley 266 and 268 are also possible. As one of ordinary skill will understand, more than two vertexes and valleys may be included in the embodiments. For example, where an embodiment includes three valve leaflets, e.g., a tricuspid valve, three vertexes and three valleys can also be included to help form the three leaflets.


The cover 222 can further include valve leaflets 240 and 242 that define the reversibly sealable opening 216 for the unidirectional flow of the fluid through the lumen 212. For example, the surfaces of the cover 222 can be deflectable between a closed configuration (FIG. 2B) in which fluid flow through the lumen 212 can be restricted and an open configuration (FIG. 2A) in which fluid flow through the lumen 212 can be permitted in response to the fluid motion and/or pressure differential across the valve leaflets 240 and 242.


The example of valve 204 shown in FIGS. 2A and 2B provide embodiments in which the surfaces defining the reversibly sealable opening 216 include the first leaflet 240 and the second leaflet 242 coupled to the valve frame 220 to provide a two-leaflet configuration (i.e., a bicuspid valve) for valve 204. Although the embodiments illustrated in FIGS. 2A and 2B of the present invention show and describe a two-leaflet configuration for valve 204, designs employing a different number of valve leaflets (e.g., tricuspid valve) are also possible.


In one embodiment, each of the valve leaflets 240 and 242 include sufficient excess material spanning valve frame 220 such that fluid pressure (e.g., antegrade flow) acting on the valve leaflets 240 and 242 forces the valve 204 into an open configuration (FIG. 2A). Valve leaflets 240 and 242 further include arcuate edges, as illustrated in FIGS. 1A and 1B and shown as 144 and 146, that are positioned adjacent each other along a substantially catenary curve between the first vertex 263 and the second vertex 264 in the closed configuration (Figure B) of valve 204. Similarly, arcuate edges 244 and 246 can help to define lumen 212 when the valve 204 is in the open configuration (FIG. 2A).


In an additional embodiment, in the open configuration the sufficient excess material spanning the valve frame 220 between the first vertex 263 and the second vertex 264 can allow the valve leaflets 240 and 242 to take on a semi-tubular structure, as shown in FIG. 2A, when fluid pressure opens the valve 204. In an additional embodiment, arcuate edge 244 and 246 of valve 204 can open to approximately the full inner diameter of body lumen.


Each of the valve leaflets 240 and 242 can further include a curve imparted thereto so as to provide a concave structure to the leaflet 240 and 242. The concave structure allows the valve leaflets 240 and 242 to better collect retrograde fluid flow to urge valve leaflets 240 and 242 towards the closed configuration (FIG. 2B). For example, as retrograde flow begins, the valve leaflets 240 and 242 respond by moving towards the center of valve 204. As the valve leaflets 240 and 242 approach the center of the device the valve leaflets 240 and 242 can make sufficient contact to effectively close the reversibly sealable opening 116 of valve 104 and thereby restrict retrograde fluid flow, i.e., second direction 197 as shown in FIGS. 1A and 1B.



FIGS. 3A and 3B provide a further illustration of the filter system 300 (i.e., the elongate filter body 302, valve 304, and filter region 350) that includes a sheath 374 having a lumen 376. FIGS. 3A and 3B provide a sectional illustration of the filter system 300 at least partially contained within a lumen 376 of the sheath 374 (FIG. 3A) and of the filter system 300 at least partially deployed from the lumen 376 of the sheath 374 (FIG. 3B).


In various embodiments, both the valve 304 and the filter region 350 of the elongate filter body 302 can be releasably positioned in a coaxial arrangement within the lumen 376 of the sheath 374. As discussed herein, the configuration of the support frame 320 provides the valve 304 with sufficient flexibility to move between the first configuration 342 (e.g., a refracted state within the lumen 376 of the sheath 374 as shown in FIG. 3A) and the second configuration 344 (e.g., an extended state outside the lumen 376 of the sheath 374 as shown in Figures FIG. 3B).


In one embodiment, the valve 304 can be configured to reside in the compressed state when retracted within the lumen 376 of the sheath 374, as illustrated in FIG. 3A, and in an expanded state when extended from the lumen 376 of the sheath 374, as illustrated in FIG. 3B. In one embodiment, the valve 304 expands from its compressed state within the lumen 376 to the deployed state when the sheath 374 is retracted from around the valve 304.


The sheath 374 can be formed of a number of materials. Materials include polymers, such as PVC, PE, POC, PET, polyamid, mixtures, and block co-polymers thereof. In addition, the sheath 374 can have a wall thickness and an inner diameter sufficient to maintain both the valve 304 and the expandable filter region 350 in the retracted state when they are positioned within the lumen 376. In an additional embodiment, the sheath 374 can further include radiopaque markers 352. For example, radiopaque markers (e.g., attached or coated) can be used to mark the location and allow for visualization of the location and position of parts of the sheath 374.


In the various embodiments, the support frame 320 of the cardiac valve 304 expands to increase the diameter 312 of the lumen 306 of the valve 304 as the valve 304 is extended from the sheath 374. In one embodiment, the diameter 312 of the lumen 306 can be determined based upon the type of body lumen and the body lumen size in which the valve 304 is to be placed. In an additional example, there can also be a minimum value for the width for the support frame 320 that ensures that the valve 304 will have an appropriate expansion force against the inner wall of the body lumen to prevent retrograde flow within the body lumen.


In addition, the lumen 306 of the elongate filter body 302 in the filter region 350 also increases in diameter as the valve 304 and the elongate filter body 302 are extended from the sheath 374. In one embodiment, the expandable filter region 350 can expand from the first configuration to the second configuration due in part to force imparted by the frame 320 as it expands and under pressure of the unidirectional flow of the fluid. In an additional embodiment, the expandable filter region 350 can be configured to radially self-expand, as the same has been described herein, when released from its compressed state within the lumen 376 of the sheath 374.


The expandable filter region 350 in its deployed state can fill the cross-section area of a body lumen in which the valve 304 and expandable filter region 350 are deployed. In addition, filter region 350 in its deployed state can apply sufficient pressure to the inner wall of the body lumen to reduce the volume of fluid (e.g., blood) that may pass between the filter region 350 and the surface of the body lumen wall. As will be appreciated, the area and shape defined by the expandable filter region 350 (e.g., the diameter of the expandable filter) in its deployed state will be dependent upon the location in which the filter system is intended to be used.


The filter system 300 can be extended and retracted from the lumen 376 of the sheath 374 in any number of ways. For example, the elongate filter body 302 can be pulled longitudinally within the lumen 376 of the sheath 374 so as to retract the valve 304 and the filter region 350 of the elongate filter body 302. In this embodiment, the elongate filter body 302, supported by the sheath 374, provides sufficient column strength to allow force imparted at the proximal end 308 of the elongate filter body 302 to retract the valve 304 and the filter region 350.


In an additional embodiment, a portion of the elongate filter body 302 extending from the filter region 350 to the proximal end 308 can be reinforced and/or have an alternative construction relative the filter region 350 so as to impart sufficient column strength to the elongate filter body 302. The elongate filter body 302 can then be pushed longitudinally within the lumen 376 of the sheath 374 so as to extend the valve 304 and the filter region 350 of the elongate filter body 302.


In an additional embodiment, the valve 304 and the filter region 350 can be deployed and retracted by moving the sheath 374 relative the elongate filter body 302. In this embodiment, the elongate filter body 302 can be held while the sheath 374 is moved longitudinally so as to either deploy or retract the valve 304 and the filter region 350.


The filter system 300 and the sheath 374 can further include handles positioned at the proximal end 308 of the elongate filter body 302 and a first sheath end 378 of the sheath 374. In one embodiment, the sheath 374 includes a handle 382 and the elongate filter body 302 includes a handle 384. Handles 382 and 384 allow the sheath 374 and the elongate filter body 302 to move relative to each other so as to extend and/or retract the valve and a portion of the elongate filter body from the lumen 376 of the sheath 374. In one embodiment, the distance between the handles 382 and 384 can correspond approximately to the length of the compacted valve 304 and the filter region 350 to effectively deploy the expandable filter region 350 and valve 304. Other configurations and relational lengths are possible.


In an additional embodiment, filter system 300 and the sheath 374 can further include a sleeve 386 having a slit 388 and a pull tab 390 positioned between the handles during delivery to prevent inadvertent exposure of the valve 304 and filter region 350. For example, the sleeve 386 can be stripped from the filter system 300 by pulling the pull tab once the sheath 374 has been placed at the predetermined location at which the valve 304 and the filter region 350 are to be deployed. Other removable structures for preventing inadvertent exposure of the valve 304 and filter region 350 are also possible.


In an additional embodiment, the filter system 300, as shown in FIG. 3C can be extended and/or retracted from the sheath 374 through the use of a deployment rod 394. In one embodiment, the deployment rod 394 extends from the proximal end 308 of the elongate filter body 302 through the lumen 376 to the fluid tight plug 354, as the same has been described in connection with FIGS. 1A and 1B. In one embodiment, the deployment rod 394 can be used to move the elongate filter body 302 and the valve 304 relative the sheath 374.


For example, the deployment rod 394 can extend through the lumen 312 to the fluid tight plug 354, where the deployment rod 394 can be used to push the filter system 300 relative the sheath 374 to deploy the valve 304 and the filter region 350 and/or pull the filter system 300 relative the sheath 374 to draw the valve 304 and the filter region 350 back into its compressed state within the lumen 376 of the sheath 374. Alternatively, the deployment rod 394 can be used to change the position of the valve 304 and filter region 350 once deployed from a first position within the lumen to a second position.


In the various embodiments, the deployment rod 394 and the fluid tight plug 354 can further include releasably interconnecting members to allow the deployment rod 394 and the fluid tight plug 354 to be separated. For example, the fluid tight plug 354 can include a socket having threads to receive and interact with a threaded portion of the deployment rod 394. This structure allows for the deployment rod 394 to be inserted through the lumen 376 of the elongate filter body 302 to the fluid tight plug 354, where the treaded portion of the deployment rod 394 can be screwed into the threaded socket of the fluid tight plug 354. The deployment rod 394 can then be removed from the lumen 376 by unscrewing the threaded portion of the deployment rod 394 from the threaded socket of the fluid tight plug 354. As will be appreciated, other ways of decoupling the deployment rod 394 and the fluid tight plug 354 are also possible.


In one embodiment, the deployment rod 394 can be formed of a number of materials. Materials include polymers, such as PVC, PE, POC, PET, polyamid, mixtures, and block co-polymers thereof. In addition, the deployment rod 394 can be formed of medical grade stainless steel (e.g., 316L), titanium, tantalum, platinum alloys, niobium alloys, cobalt alloys, alginate, or combinations thereof.



FIGS. 4A-4D provides a further illustration of the filter system 400 that includes the sheath 474, as previously discussed, and a catheter 401 and an apparatus 445. FIGS. 4A-4D provide perspective illustrations of the filter system 400 at least partially contained within the lumen 476 of the sheath 474, with the catheter 401 and the apparatus 445 at least partially contained within a lumen 406 of the elongate filter body 402.


Examples of the catheter 401 and the apparatus 445 are illustrated in U.S. patent application Ser. No. 11/049,000, entitled “Vascular Catheter, System, and Method”, which is hereby incorporated by reference in its entirety. In the various embodiments, the catheter 401 includes an elongate body 403 having a first lumen 405 extending between a proximal end 407 and a distal end 409. In one embodiment, the first lumen 405 allows for additional elongate members to travel along a longitudinal axis of the elongate body 402.


The catheter 401 further includes a first cutting head 411 having a blade 413 and an elongate pulling member 415. The first cutting head 411 can be positioned adjacent the distal end 409 of the elongate body 403 of the catheter 401 with the elongate pulling member 415 extending through the first lumen 405. In one embodiment, the elongate pulling member 415 can slide within the first lumen 405 to move the first cutting head 411 relative the distal end 409 of the elongate body 403 of the catheter 401.


The catheter 401 also includes a second cutting head 417 having a blade 419. The second cutting head 417 can be positioned adjacent the distal end 409 of the elongate body 403 between the distal end 409 and the first cutting head 411. The blade 413 of the first cutting head 411 can move relative the blade 419 of the second cutting head 417 to provide a shearing action. In one example, the shearing action can be sufficient for cutting cardiac tissue.



FIG. 4A further illustrates an embodiment in which the second cutting head includes an elongate pushing member 421. In one embodiment, the elongate pushing member 421 can slide within the first lumen 405 to move the second cutting head 417 relative the distal end 409 of the elongate body 403 and the first cutting head 411. In one embodiment, the elongate pulling member 415 can be arranged concentrically with the elongate pushing member 421 in the first lumen 405.


As illustrated, the elongate pulling member 415, the elongate pushing member 421 and the first lumen 405 of the elongate body 403 can be positioned coaxially. In one embodiment, the lumen 405 has a diameter sufficient to accommodate the elongate pushing member 421. Similarly, the elongate pushing member 421 had a diameter sufficient to accommodate the elongate pulling member 415.


In addition, the elongate pulling member 415 and the elongate pushing member 421 can be structured such that their relative rotational movement is restricted. In other words, relative axial rotation of the elongate pulling member 415 and the elongate pushing member 421 is restricted due to the structure of the members 415 and 421. For example, this can be accomplished using one or more physical structures formed in and/or attached to the members 415 and 421. In one embodiment, one of the members 415 or 421 can include a channel through which an extension from the other of the members 415 or 421 can travel so as to inhibit axial rotation of the members 415 and 421. Alternatively, the members 415 and 421 could have a cross-sectional shape that inhibits relative axial rotation. Examples of such cross-sectional shapes include oval or elliptical cross-sectional shapes. Other shapes are also possible.


In addition to providing a sufficient diameter, a gap can exist between the opposing surfaces of the first lumen 405 and the elongate pushing member 421 to allow the elongate pushing member 421 to move through the first lumen 405 from force applied at the proximal end of the elongate pushing member 421. Similarly, a gap can exist between the opposing surfaces of the elongate pushing member 421 and the elongate pulling member 415 to allow the elongate pushing member 421 and the elongate pulling member 415 to move relative each other from force applied at the proximal end of the elongate pushing member 421 and/or the elongate pulling member 415. The elongate pull member 415 can further include a lumen 471 for tracking over a guidewire. A lubricant can be included on the surfaces of the elongate pulling member 415, the elongate pushing member 421 and the first lumen 405.


The first cutting head 411 further includes a shape conducive to passing the catheter 401 and the filter system 400 through a body lumen (e.g., a lumen of the cardiovascular system). For example, the first cutting head 411 can include a conical shape having a first end 423 and a second end 425, where the first end 423 has a diameter that is less than a diameter of the second end 425. Other shapes are also possible. In addition, the shape of the first cutting head 411 can be configured to protectively house the blade 413 from structures passing by the first end 423 towards the second end 425. In other words, the shape of the first cutting head 411 can be used to shield the blade 413 from unintentionally interfering and/or cutting tissue within a body lumen.


In one embodiment, the blade 413 can be radially positioned relative the elongate pulling member 415 generally along the second end 425 of the first cutting head 411. As will be appreciated, the first cutting head 411 can include more than one blade 413. Each blade 413 and 419 further includes a cutting edge 427 and 429, respectively, in alignment so as to provide shearing action between a pair of the cutting edges 427 and 429 of the blades 413 and 419. For example, the first cutting head 411 can move relative the second cutting head 417 to allow the cutting edge 427 of the blade 413 of the first cutting head 411 to slide past the cutting edge 429 of the blade 417 of the second cutting head 417. Example of suitable materials for the blades 413 and 419 include, but are not limited to, stainless steel (e.g., 316L) and titanium.


In one embodiment, blades 413 and 419 can be secured to the first cutting head 411 and the second cutting head 417, respectively, in any number of ways. For example, blades 413 and 419 can be secured to the cutting heads 411 and 417 through the use of mechanical fasteners, such as screws, and/or interlocking pins and sockets. In addition, blades 413 and 419 can be secured to the cutting heads 411 and 417 through the use of chemical adhesives. Examples of such chemical adhesives include, but are not limited to, medical grade adhesives such as cyanoacrylate, acrylic, silicone, and urethane adhesives.


In an additional embodiment, the first cutting head 411 can be configured to receive and house at least a portion of the second cutting head 417, including the blade 419, such that the second blade 419 does not pass beyond the first cutting head 411. For example, the first cutting head can include a socket that extends radially relative the elongate pulling member 415 and distally from the blade 413 to receive the blade 419 of the second cutting head 417 as the blade 419 passes the blade 413. In one embodiment, the blade 419 can be positioned within the socket of the first cutting head 411 as the catheter 401 is moved through a lumen.


Catheter 401 can have various lengths between the proximal end 407 and the first cutting head 411. In one embodiment, the length between the proximal end 407 and the first cutting head 411 is sufficient to allow the catheter 401 to be percutaneously implanted through a patient's vasculature to position the cutting heads (e.g., the first and second cutting heads) at a predetermined location. Examples of the predetermined locations include, but are not limited to, cardiovascular locations such as on or adjacent to a cardiac valve of the heart (e.g., the aortic valve), including within a chamber of the patient's heart (e.g., the left ventricle of the heart). As will be appreciated, the length between the proximal end 407 and the first cutting head 411 will be dependent upon each patient's physiological structure and the predetermined location within the patient.


The elongate body 403 of the catheter 401, the elongate pulling member 415, the elongate pushing member 421, the second cutting head 417 and the first cutting head 411 can be formed from a wide variety of materials and in a wide variety of configurations. For example, the materials may include, but are not limited to, one or more of polyvinyl chloride (PVC), polyethylene (PE), polyolefin copolymer (POC), polyethylene terephthalate (PET), polyamid, mixtures, and block co-polymers thereof. Alternatively, the materials may include one or more alloys in any number of configurations. For example, the materials may include stainless steel (e.g., 316L), titanium, or other medical grade alloys as are known. These materials may also have a woven configuration or a solid extruded configuration.


The selection of material and configuration allows for the elongate body 403, the elongate pulling member 415, the elongate pushing member 421, the second cutting head 417 and the first cutting head 411 to each have the flexibility, and the ability to be either pushed and/or pulled thereby accomplishing the actions described for the components herein. As will be appreciated, selection of the material can be based generally on a broad range of technical properties, including, but not limited to, modulus of elasticity, flexural modulus, and Shore A hardness required for the embodiments of the present invention. Components of the present apparatus and/or system can also be coated for lubrication, for abrasion resistance, or to deliver an anticoagulatory drug.


As an alternative configuration, the cutting mechanism of first cutting head 411 and second cutting head 417 can be accomplished by alternate cutting, shearing, slicing, grinding or ablative means as are known for other purposes. For example, thermal energy can be used to weaken or slice the diseased valve, rolling cutters could be incorporated, or a “cutting balloon” mechanism could be incorporated.


In an additional embodiment, the catheter 401 can further include radiopaque markers 431. For example, radiopaque markers (e.g., attached or coated) can be used to mark the location of the first cutting head 411 and the second cutting head 417. In addition, radiopaque markers can be used to mark the location of blades 413 and 419. Other portions of catheter 401 can also be marked with radiopaque markers as necessary to allow for visualization of the location and position of parts of the catheter 401.


As illustrated in FIG. 4A, catheter 401 can reside at least partially within the lumen 406 of the elongate filter body. FIG. 4B provides an example in which both the valve 404 and the filter region 450 have been extended from the sheath 474, as discussed herein, with the catheter 401 at least partially extending distally from the valve 404. In the various embodiments, the valve leaflets of valve 404 can seat around the elongate body 403 of the catheter 401 to provide the reversibly sealable opening of the valve 404.


In the various embodiments, the elongate body 403 can travel longitudinally within the lumen 406 of the elongate filter body 402 to extend and retract the distal end 409 of the catheter 401 relative the valve 404 of the filter system 400. The elongate filter body 402 can further include a sealing ring that allows the elongate body 403 of the catheter 401 to move longitudinally while maintaining a fluid tight seal within the lumen 406 of the elongate filter body 402.


In addition to the structures described herein, the elongate body 403 of catheter 401 further includes a second lumen 435, as shown in FIG. 4A. In one embodiment, the second lumen 435 can extend between the proximal end 407 and the distal end 409 of the elongate body 403, where the second lumen 435 can be coupled in fluid tight communication to an inflatable balloon 437 on the elongate body 403. The catheter 401 can further include an inflation device 495 that can reversibly couple in fluid tight communication with the second lumen 435 to provide fluid pressure to inflate and deflate balloon 437.


In one embodiment, the inflatable balloon 437 can be positioned adjacent the distal end 409 of the elongate body 403 and proximal to the second cutting head 417. The inflatable balloon 437 can be inflated from a deflated state to an inflated state by pressure applied by fluid moving through the second lumen 435. In addition, the catheter 401 further includes an expandable stent 439 positioned over at least a portion of the inflatable balloon 437. The expandable stent 439 can move between a compressed state, as shown in FIG. 4B, and an expanded state, as shown in FIG. 4C, using the inflatable balloon 437. In one embodiment, the expandable stent 439 can be deployed over cardiac tissue sheared using the first and second cutting heads 411 and 417 using the inflatable balloon 437.


Catheter 401 can further include an annular push ring 441 positioned between the second cutting head 417 and the inflatable balloon 437. The annular push ring 441 can be used for contacting and moving at least a portion of cardiac tissue sheared with the first and second cutting heads 411 and 417. For example, the first and second cutting heads 411 and 417 can be used to shear cardiac tissue (e.g., one or more cusps of a valve). The annular push ring 441 can then be advanced into contact with the sheared cardiac tissue. As the annular push ring 441 advances the sheared cardiac tissue can be directed towards the wall of the lumen. Stent 439 can then be positioned over at least a portion of the sheared cardiac tissue positioned using the annular push ring 441. Stent 439 can then be deployed using the inflatable balloon 437 to position at least a portion of the sheared cardiac tissue between the expanded stent 439 and the wall of the lumen. As will be appreciated, the dimensions and physical characteristics of the stent 439 will be dependent upon the location in which the stent 439 is to be implanted.


The apparatus 445 can further include a cardiac valve 455. The cardiac valve 455 can be releasably positioned adjacent the expandable stent 439 over at least a portion of the inflatable balloon 437. Generally, cardiac valve 455 can be implanted within the fluid passageway of a body lumen, such as for replacement of a valve structure within the body lumen to regulate the flow of a bodily fluid through the body lumen in a single direction.


With respect to the apparatus 445, the cardiac valve 455 can be configured to reside in a compressed state over at least a portion of the inflatable balloon 437. Using the inflatable balloon, the cardiac valve 455 can be expanded into a deployed state as illustrated in FIGS. 4C and 4D.


One example of cardiac valve 455 includes valve 204 as described herein. An additional embodiment of cardiac valve 455 is illustrated in U.S. patent application Ser. No. 11/049,000, entitled “Vascular Catheter, System, and Method”, which is hereby incorporated by reference in its entirety.


Generally, the cardiac valve 455 includes a support frame and a cover. The cover of the cardiac valve 455 can be positioned over at least the outer surface of the support frame. In one embodiment, the cover includes surfaces defining a reversibly sealable opening for unidirectional flow of a liquid through the lumen of the cardiac valve 455.


The filter system 400, catheter 401 and the apparatus 445 can further include handles to allow the various components to be moved relative each other. For example, handles 479 can allow the elongate pushing member 421 and/or the elongate pulling member 415 to be moved relative each other. Handle 481 can allow the catheter 401 to be moved relative the apparatus 445 and the sheath 474. In addition, handles 483 can allow the sheath 474 and the filter system 400 to be moved relative each other. As will be appreciated, other structures may be used in place of or in addition to the handles to allow the various components of the filter system 400, catheter 401, and apparatus 445 to move relative each other.


The embodiments of the present invention further include methods for forming the filter system and apparatus, as discussed herein. For example, embodiments of the present invention can be formed by providing an elongate filter body that includes the expandable filter region defining a lumen. The valve can further be provided, where the valve can be adjoined proximal the distal end of the elongate filter body to form a single lumen through which fluid flows unidirectionally through the valve and the elongate filter body to filter the fluid. As provided herein, the valve can define a reversibly sealable opening for the unidirectional flow of fluid through the lumen of the valve.


In one embodiment, the expandable filter region can be configured to move between a first configuration and a second configuration. In one embodiment, the movement from the first configuration to the second configuration can occur as the valve expands in addition to under pressure of the unidirectional flow of the fluid. The elongate filter body can also be provided with the fluid tight plug to direct the unidirectional flow of the fluid from the lumen through the expandable filter region to filter the unidirectional flow of the fluid. In these embodiments, the fluid tight plug can include various shapes and sizes and can be positioned according to the embodiments described herein.


In various embodiments, the valve can be provided with a support frame having various configurations. A first configuration can include a compressed configuration and a second configuration can include an expanded configuration. In various embodiments, expansion of the support frame can be supplemented by fluid flowing into the lumen of the elongate filter body.


The filter system and apparatus, as discussed herein, can further include providing the catheter having the first cutting head and the second cutting head, as discussed herein. The first cutting head can include the blade and the elongate pulling member, where the first cutting head can be positioned proximal the distal end of the elongate body with the elongate pulling member extending through the first lumen of the catheter. The elongate pulling member can then slides within the first lumen to move the first cutting head relative the distal end of the elongate body. The second cutting head can also include a blade, and be positioned adjacent the distal end of the elongate body between the distal end and the first cutting head. The blade of the first cutting head can be moved relative the blade of the second cutting head to provide the shearing action for cardiac tissue. The catheter extends though the lumen of the elongate filter body and the lumen of the valve.


In additional embodiments, the filter system and apparatus further include providing a second lumen to the elongate body, where the second lumen can be in fluid tight communication with the inflatable balloon positioned adjacent the distal end of the elongate body and proximal to the second cutting head. The expandable stent can then be positioned over at least a portion of the inflatable balloon, where the inflatable balloon deploys the expandable stent over sheared cardiac tissue. In further embodiment, the annular push ring can also be provided between the second cutting head and the inflatable balloon for contacting and moving at least a portion of the sheared cardiac tissue. The embodiments can also include providing the cardiac valve positioned over the inflatable balloon, where the cardiac valve can be deployed through the use of the inflatable balloon.


While the present invention has been shown and described in detail above, it will be clear to the person skilled in the art that changes and modifications may be made without departing from the spirit and scope of the invention. As such, that which is set forth in the foregoing description and accompanying drawings is offered by way of illustration only and not as a limitation. The actual scope of the invention is intended to be defined by the following claims, along with the full range of equivalents to which such claims are entitled.


In addition, one of ordinary skill in the art will appreciate upon reading and understanding this disclosure that other variations for the invention described herein can be included within the scope of the present invention. For example, the support frame 120 and/or the cover 122 can be coated with a non-thrombogenic biocompatible material, as are known or will be known.


In the foregoing Detailed Description, various features are grouped together in several embodiments for the purpose of streamlining the disclosure. This method of disclosure is not to be interpreted as reflecting an intention that the embodiments of the invention require more features than are expressly recited in each claim. Rather, as the following claims reflect, inventive subject matter lies in less than all features of a single disclosed embodiment. Thus, the following claims are hereby incorporated into the Detailed Description, with each claim standing on its own as a separate embodiment.

Claims
  • 1. A filter system for use in a body lumen, comprising: an elongate filter body having a tubular shaft including an expandable filter region attached at a distal end of the shaft defining a lumen extending from a proximal end of the tubular shaft toward a distal end of the filter region, the expandable filter region; anda valve defining a valve lumen and having a reversibly sealable opening for unidirectional flow of a fluid through the valve lumen, the valve fixedly attached to the expandable filter region of the elongate filter body, the valve including a frame having a first elliptical member and a second elliptical member meeting at an angle;wherein the frame is radially movable between a compressed state and an expanded state;wherein the expandable filter region filters the unidirectional flow of the fluid passing through the valve lumen and the expandable filter region in the expanded state.
  • 2. The filter system of claim 1, wherein the reversibly sealable opening is formed by one or more valve leaflets configured to move between an open configuration and a closed configuration.
  • 3. The filter system of claim 2, wherein the valve includes a cover forming the one or more valve leaflets joined to the frame.
  • 4. The filter system of claim 2, wherein the one or more valve leaflets are configured to open and close in response to fluid motion across the one or more valve leaflets.
  • 5. The filter system of claim 2, wherein the one or more valve leaflets are configured to open and close in response to pressure differential across the one or more valve leaflets.
  • 6. The filter system of claim 2, wherein the one or more valve leaflets include a first leaflet and a second leaflet coupled to the frame.
  • 7. The filter system of claim 2, wherein the one or more valve leaflets are constructed from a fluid impermeable biocompatible material.
  • 8. The filter system of claim 1, wherein the lumen of the filter body and the valve lumen are contiguous.
  • 9. The filter system of claim 1, wherein the first elliptical member and the second elliptical member meet at a first region and a second region opposite the first region across a central axis of the valve lumen.
  • 10. The filter system of claim 9, wherein the first region and the second region are positioned adjacent a minor axis of the first elliptical member and the second elliptical member.
  • 11. The filter system of claim 9, wherein the first region and the second region are positioned away from a minor axis of the first elliptical member and the second elliptical member.
  • 12. The filter system of claim 1, wherein the first elliptical member and the second elliptical member are configured to exert an expansion force against an inner wall of the body lumen in the expanded state.
  • 13. The filter system of claim 1, wherein the expandable filter region is configured to trap particulate matter present in the unidirectional flow of the fluid passing through the valve lumen.
  • 14. The filter system of claim 13, wherein the filter body is configured to remove particulate matter trapped by the expandable filter region through the tubular shaft.
  • 15. The filter system of claim 1, wherein the valve is coupled to the expandable filter region proximal of a distal end of the elongate filter body.
  • 16. The filter system of claim 15, wherein the expandable filter region is configured to radially self-expand from a compressed state to an expanded state when released from the compressed state.
  • 17. The filter system of claim 1, wherein the expandable filter region include a woven configuration, a braided configuration, or a knit configuration.
  • 18. The filter system of claim 1, wherein the elongate filter body further includes a fluid tight plug positioned within the lumen at the distal end of the tubular shaft.
  • 19. The filter system of claim 18, wherein the fluid tight plug is positioned proximal of the expandable filter region, thereby directing the unidirectional flow of the fluid passing through the valve lumen through the expandable filter region.
RELATED APPLICATIONS

This application is a continuation of U.S. application Ser. No. 11/049,019, filed Feb. 1, 2005.

US Referenced Citations (637)
Number Name Date Kind
3671979 Moulopoulos Jun 1972 A
4291420 Reul Sep 1981 A
4787901 Baykut Nov 1988 A
4872874 Taheri Oct 1989 A
4935030 Alonso Jun 1990 A
4994077 Dobben Feb 1991 A
5002567 Bona et al. Mar 1991 A
5141491 Bowald Aug 1992 A
5163953 Vince Nov 1992 A
5219355 Parodi et al. Jun 1993 A
5254127 Wholey et al. Oct 1993 A
5300086 Gory Apr 1994 A
5327774 Nguyen et al. Jul 1994 A
5332402 Teitelbaum Jul 1994 A
5370685 Stevens Dec 1994 A
5411552 Andersen et al. May 1995 A
5469868 Reger Nov 1995 A
5480423 Ravenscroft et al. Jan 1996 A
5500014 Quijano et al. Mar 1996 A
5545214 Stevens Aug 1996 A
5554185 Block et al. Sep 1996 A
5643208 Parodi Jul 1997 A
5693087 Parodi Dec 1997 A
5713953 Vallana et al. Feb 1998 A
5716370 Williamson, IV et al. Feb 1998 A
5735859 Fischell et al. Apr 1998 A
5741326 Solovay Apr 1998 A
5741333 Frid Apr 1998 A
5800506 Perouse Sep 1998 A
5824061 Quijano et al. Oct 1998 A
5879320 Cazenave Mar 1999 A
5895419 Tweden et al. Apr 1999 A
5910170 Reimink et al. Jun 1999 A
6007557 Ambrisco Dec 1999 A
6010531 Donlon et al. Jan 2000 A
6042607 Williamson, IV et al. Mar 2000 A
6139575 Shu et al. Oct 2000 A
6287334 Moll et al. Sep 2001 B1
6312447 Grimes Nov 2001 B1
6355030 Aldrich et al. Mar 2002 B1
6402780 Williamson, IV et al. Jun 2002 B2
6419696 Ortiz et al. Jul 2002 B1
6425916 Garrison et al. Jul 2002 B1
6440164 DiMatteo Aug 2002 B1
6451054 Stevens Sep 2002 B1
6454799 Schreck Sep 2002 B1
6461366 Seguin Oct 2002 B1
6503272 Duerig et al. Jan 2003 B2
6508833 Pavcnik et al. Jan 2003 B2
6564805 Garrison et al. May 2003 B2
6569196 Vesely May 2003 B1
6602286 Strecker Aug 2003 B1
6629534 St. Goar et al. Oct 2003 B1
6635085 Caffey et al. Oct 2003 B1
6666885 Moe Dec 2003 B2
6666886 Tranquillo et al. Dec 2003 B1
6669725 Scott Dec 2003 B2
6673090 Root Jan 2004 B2
6673109 Cox Jan 2004 B2
6676698 McGuckin, Jr. et al. Jan 2004 B2
6676702 Mathis Jan 2004 B2
6682558 Tu et al. Jan 2004 B2
6682559 Myers et al. Jan 2004 B2
6685739 DiMatteo et al. Feb 2004 B2
6692512 Jang Feb 2004 B2
6695866 Kuehn et al. Feb 2004 B1
6695878 McGuckin, Jr. et al. Feb 2004 B2
6709456 Langberg et al. Mar 2004 B2
6709457 Otte et al. Mar 2004 B1
6716241 Wilder et al. Apr 2004 B2
6716244 Klaco Apr 2004 B2
6719767 Kimblad Apr 2004 B1
6719784 Henderson Apr 2004 B2
6719786 Ryan et al. Apr 2004 B2
6719787 Cox Apr 2004 B2
6719788 Cox Apr 2004 B2
6719789 Cox Apr 2004 B2
6719790 Brendzel et al. Apr 2004 B2
6723038 Schroeder et al. Apr 2004 B1
6723122 Yang et al. Apr 2004 B2
6723123 Kazatchkov et al. Apr 2004 B1
6726715 Sutherland Apr 2004 B2
6726716 Marquez Apr 2004 B2
6726717 Alfieri et al. Apr 2004 B2
6730118 Spenser et al. May 2004 B2
6730121 Ortiz et al. May 2004 B2
6730122 Pan et al. May 2004 B1
6736845 Marquez et al. May 2004 B2
6736846 Cox May 2004 B2
6749630 McCarthy et al. Jun 2004 B2
6752813 Goldfarb et al. Jun 2004 B2
6752828 Thornton Jun 2004 B2
6755857 Peterson et al. Jun 2004 B2
6761734 Suhr Jul 2004 B2
6761735 Eberhardt et al. Jul 2004 B2
6764494 Menz et al. Jul 2004 B2
6764508 Roehe et al. Jul 2004 B1
6764509 Chinn et al. Jul 2004 B2
6764510 Vidlund et al. Jul 2004 B2
6767362 Schreck Jul 2004 B2
6769434 Liddicoat et al. Aug 2004 B2
6770083 Seguin Aug 2004 B2
6780200 Jansen Aug 2004 B2
6786924 Ryan et al. Sep 2004 B2
6786925 Schoon et al. Sep 2004 B1
6790229 Berreklouw Sep 2004 B1
6790230 Beyersdorf et al. Sep 2004 B2
6790231 Liddicoat et al. Sep 2004 B2
6793673 Kowalsky et al. Sep 2004 B2
6797000 Simpson et al. Sep 2004 B2
6797001 Mathis et al. Sep 2004 B2
6797002 Spence et al. Sep 2004 B2
6802860 Cosgrove et al. Oct 2004 B2
6805710 Bolling et al. Oct 2004 B2
6805711 Quijano et al. Oct 2004 B2
6810882 Langberg et al. Nov 2004 B2
6821297 Snyders Nov 2004 B2
6824562 Mathis et al. Nov 2004 B2
6830584 Seguin Dec 2004 B1
6830585 Artof et al. Dec 2004 B1
6837902 Nguyen et al. Jan 2005 B2
6840246 Downing Jan 2005 B2
6840957 DiMatteo et al. Jan 2005 B2
6846324 Stobie Jan 2005 B2
6846325 Liddicoat Jan 2005 B2
6858039 McCarthy Feb 2005 B2
6869444 Gabbay Mar 2005 B2
6872226 Cali et al. Mar 2005 B2
6875224 Grimes Apr 2005 B2
6875230 Morita et al. Apr 2005 B1
6875231 Anduiza et al. Apr 2005 B2
6881199 Wilk et al. Apr 2005 B2
6881224 Kruse et al. Apr 2005 B2
6883522 Spence et al. Apr 2005 B2
6890352 Lentell May 2005 B1
6890353 Cohn et al. May 2005 B2
6893459 Macoviak May 2005 B1
6893460 Spenser et al. May 2005 B2
6896700 Lu et al. May 2005 B2
6902576 Drasler et al. Jun 2005 B2
6908478 Alferness et al. Jun 2005 B2
6908481 Cribier Jun 2005 B2
6911043 Myers et al. Jun 2005 B2
6913608 Liddicoat et al. Jul 2005 B2
6916338 Speziali Jul 2005 B2
6918917 Nguyen et al. Jul 2005 B1
6921407 Nguyen et al. Jul 2005 B2
6921811 Zamora et al. Jul 2005 B2
6926715 Hauck et al. Aug 2005 B1
6926730 Nguyen et al. Aug 2005 B1
6929653 Strecter Aug 2005 B2
6932838 Schwartz et al. Aug 2005 B2
6936067 Buchanan Aug 2005 B2
6939359 Tu et al. Sep 2005 B2
6942694 Liddicoat et al. Sep 2005 B2
6945957 Freyman Sep 2005 B2
6945978 Hyde Sep 2005 B1
6945996 Sedransk Sep 2005 B2
6945997 Huynh et al. Sep 2005 B2
6949122 Adams et al. Sep 2005 B2
6951571 Srivastava Oct 2005 B1
6951573 Dilling Oct 2005 B1
6953332 Kurk et al. Oct 2005 B1
6955689 Ryan et al. Oct 2005 B2
6958076 Acosta et al. Oct 2005 B2
6962605 Cosgrove et al. Nov 2005 B2
6964682 Nguyen-Thien-Nhon et al. Nov 2005 B2
6964683 Kowalsky et al. Nov 2005 B2
6964684 Ortiz et al. Nov 2005 B2
6966925 Stobie Nov 2005 B2
6966926 Mathis Nov 2005 B2
6974464 Quijano et al. Dec 2005 B2
6974474 Pavcnik et al. Dec 2005 B2
6974476 McGuckin, Jr. et al. Dec 2005 B2
6976995 Mathis et al. Dec 2005 B2
6979350 Moll et al. Dec 2005 B2
6986775 Morales et al. Jan 2006 B2
6989027 Allen et al. Jan 2006 B2
6989028 Lashinski et al. Jan 2006 B2
6997950 Chawla Feb 2006 B2
6997951 Solem et al. Feb 2006 B2
7004176 Lau Feb 2006 B2
7007396 Rudko et al. Mar 2006 B2
7011669 Kimblad Mar 2006 B2
7011681 Vesely Mar 2006 B2
7011682 Lashinski et al. Mar 2006 B2
7018406 Seguin et al. Mar 2006 B2
7018407 Wright et al. Mar 2006 B1
7018408 Bailey et al. Mar 2006 B2
7022134 Quijano et al. Apr 2006 B1
7025780 Gabbay Apr 2006 B2
7033390 Johnson et al. Apr 2006 B2
7037333 Myers et al. May 2006 B2
7037334 Hlavka et al. May 2006 B1
7041128 McGuckin, Jr. et al. May 2006 B2
7041132 Quijano et al. May 2006 B2
7044966 Svanidze et al. May 2006 B2
7044967 Solem et al. May 2006 B1
7048754 Martin et al. May 2006 B2
7048757 Shaknovich May 2006 B2
7052487 Cohn et al. May 2006 B2
7052507 Wakuda et al. May 2006 B2
7063722 Marquez Jun 2006 B2
7066954 Ryan et al. Jun 2006 B2
7070616 Majercak et al. Jul 2006 B2
7070618 Streeter Jul 2006 B2
7077862 Vidlund et al. Jul 2006 B2
7081131 Thornton Jul 2006 B2
7087064 Hyde Aug 2006 B1
7089051 Javerud et al. Aug 2006 B2
7090695 Solem et al. Aug 2006 B2
7854755 Lafontaine Dec 2010 B2
7959666 Salahieh Jun 2011 B2
7988724 Salahieh Aug 2011 B2
8012198 Hill Sep 2011 B2
8460368 Taylor Jun 2013 B2
8747458 Tuval Jun 2014 B2
20020013571 Goldfarb et al. Jan 2002 A1
20020026216 Grimes Feb 2002 A1
20020082630 Menz et al. Jun 2002 A1
20020123802 Snyders Sep 2002 A1
20020151970 Garrison et al. Oct 2002 A1
20020183835 Taylor et al. Dec 2002 A1
20020183838 Liddicoat et al. Dec 2002 A1
20020198594 Schreck Dec 2002 A1
20030050694 Yang et al. Mar 2003 A1
20030055492 Shaolian Mar 2003 A1
20030130729 Paniagua et al. Jul 2003 A1
20030163194 Quijano et al. Aug 2003 A1
20030167071 Martin et al. Sep 2003 A1
20030171806 Mathis et al. Sep 2003 A1
20030199975 Gabbay Oct 2003 A1
20030229394 Ogle et al. Dec 2003 A1
20030229395 Cox Dec 2003 A1
20030233142 Morales et al. Dec 2003 A1
20030236568 Hojeibane et al. Dec 2003 A1
20030236569 Mathis et al. Dec 2003 A1
20040002719 Oz et al. Jan 2004 A1
20040003819 St. Goar et al. Jan 2004 A1
20040010305 Alferness et al. Jan 2004 A1
20040015230 Moll et al. Jan 2004 A1
20040015232 Shu et al. Jan 2004 A1
20040015233 Jansen Jan 2004 A1
20040019374 Hojeibane et al. Jan 2004 A1
20040019377 Taylor et al. Jan 2004 A1
20040019378 Hlavka et al. Jan 2004 A1
20040024447 Haverich Feb 2004 A1
20040024451 Johnson et al. Feb 2004 A1
20040024452 Kruse et al. Feb 2004 A1
20040030321 Fangrow, Jr. Feb 2004 A1
20040030381 Shu Feb 2004 A1
20040030382 St. Goar et al. Feb 2004 A1
20040030405 Carpentier et al. Feb 2004 A1
20040034380 Woolfson et al. Feb 2004 A1
20040034411 Quijano et al. Feb 2004 A1
20040039436 Spenser et al. Feb 2004 A1
20040039442 St. Goar et al. Feb 2004 A1
20040039443 Solem et al. Feb 2004 A1
20040044350 Martin et al. Mar 2004 A1
20040044365 Bachman Mar 2004 A1
20040044403 Bischoff et al. Mar 2004 A1
20040049207 Goldfarb et al. Mar 2004 A1
20040049211 Tremulis et al. Mar 2004 A1
20040049266 Anduiza et al. Mar 2004 A1
20040059351 Eigler et al. Mar 2004 A1
20040059411 Strecker Mar 2004 A1
20040059412 Lytle, IV et al. Mar 2004 A1
20040060161 Leal et al. Apr 2004 A1
20040073301 Donlon et al. Apr 2004 A1
20040073302 Rourke et al. Apr 2004 A1
20040078072 Tu et al. Apr 2004 A1
20040078074 Anderson et al. Apr 2004 A1
20040082910 Constantz et al. Apr 2004 A1
20040082923 Field Apr 2004 A1
20040082991 Nguyen et al. Apr 2004 A1
20040087975 Lucatero et al. May 2004 A1
20040088045 Cox May 2004 A1
20040088046 Speziali May 2004 A1
20040092858 Wilson et al. May 2004 A1
20040093060 Seguin et al. May 2004 A1
20040093070 Hojeibane et al. May 2004 A1
20040093080 Helmus et al. May 2004 A1
20040097979 Svanidze et al. May 2004 A1
20040098098 McGuckin, Jr. et al. May 2004 A1
20040098112 DiMatteo et al. May 2004 A1
20040102839 Cohn et al. May 2004 A1
20040102840 Solem et al. May 2004 A1
20040102842 Jansen May 2004 A1
20040106976 Bailey et al. Jun 2004 A1
20040106990 Spence et al. Jun 2004 A1
20040106991 Hopkins et al. Jun 2004 A1
20040111096 Tu et al. Jun 2004 A1
20040117009 Cali et al. Jun 2004 A1
20040122448 Levine Jun 2004 A1
20040122512 Navia et al. Jun 2004 A1
20040122513 Navia et al. Jun 2004 A1
20040122514 Fogarty et al. Jun 2004 A1
20040122515 Chu Jun 2004 A1
20040122516 Fogarty et al. Jun 2004 A1
20040127979 Wilson et al. Jul 2004 A1
20040127980 Kowalsky et al. Jul 2004 A1
20040127981 Rahdert et al. Jul 2004 A1
20040127982 Machold et al. Jul 2004 A1
20040133220 Lashinski et al. Jul 2004 A1
20040133267 Lane Jul 2004 A1
20040133273 Cox Jul 2004 A1
20040138742 Myers et al. Jul 2004 A1
20040138743 Myers et al. Jul 2004 A1
20040138744 Lashinski et al. Jul 2004 A1
20040138745 Macoviak et al. Jul 2004 A1
20040148018 Carpentier et al. Jul 2004 A1
20040148019 Vidlund et al. Jul 2004 A1
20040148020 Vidlund et al. Jul 2004 A1
20040153052 Mathis Aug 2004 A1
20040153146 Lashinski et al. Aug 2004 A1
20040153147 Mathis Aug 2004 A1
20040158321 Reuter et al. Aug 2004 A1
20040162610 Liska et al. Aug 2004 A1
20040167539 Kuehn et al. Aug 2004 A1
20040167620 Ortiz et al. Aug 2004 A1
20040172046 Hlavka et al. Sep 2004 A1
20040176839 Huynh et al. Sep 2004 A1
20040176840 Langberg et al. Sep 2004 A1
20040181238 Zarbatany et al. Sep 2004 A1
20040186444 Daly et al. Sep 2004 A1
20040186558 Pavcnik et al. Sep 2004 A1
20040186561 McGuckin, Jr. et al. Sep 2004 A1
20040186563 Lobbi Sep 2004 A1
20040186565 Schreck Sep 2004 A1
20040186566 Hindrichs et al. Sep 2004 A1
20040193191 Starksen et al. Sep 2004 A1
20040193253 Thorpe et al. Sep 2004 A1
20040193260 Alferness et al. Sep 2004 A1
20040199155 Mollenauer Oct 2004 A1
20040199183 Oz et al. Oct 2004 A1
20040199191 Schwartz Oct 2004 A1
20040204758 Eberhardt et al. Oct 2004 A1
20040206363 McCarthy et al. Oct 2004 A1
20040210240 Saint Oct 2004 A1
20040210301 Obermiller Oct 2004 A1
20040210303 Sedransk Oct 2004 A1
20040210304 Seguin et al. Oct 2004 A1
20040210305 Shu et al. Oct 2004 A1
20040210306 Quijano et al. Oct 2004 A1
20040210307 Khairkhahan Oct 2004 A1
20040215333 Duran et al. Oct 2004 A1
20040215339 Drasler et al. Oct 2004 A1
20040220654 Mathis et al. Nov 2004 A1
20040220657 Nieminen et al. Nov 2004 A1
20040225322 Garrison et al. Nov 2004 A1
20040225344 Hoffa et al. Nov 2004 A1
20040225348 Case et al. Nov 2004 A1
20040225352 Osborne et al. Nov 2004 A1
20040225353 McGuckin, Jr. et al. Nov 2004 A1
20040225354 Allen et al. Nov 2004 A1
20040225355 Stevens Nov 2004 A1
20040225356 Frater Nov 2004 A1
20040230117 Tosaya et al. Nov 2004 A1
20040230297 Thornton Nov 2004 A1
20040236411 Sarac et al. Nov 2004 A1
20040236418 Stevens Nov 2004 A1
20040236419 Milo Nov 2004 A1
20040243153 Liddicoat et al. Dec 2004 A1
20040243219 Fischer et al. Dec 2004 A1
20040243227 Starksen et al. Dec 2004 A1
20040243228 Kowalsky et al. Dec 2004 A1
20040243230 Navia et al. Dec 2004 A1
20040249452 Adams et al. Dec 2004 A1
20040254600 Zarbatany et al. Dec 2004 A1
20040254601 Eskuri Dec 2004 A1
20040254636 Flagle et al. Dec 2004 A1
20040260276 Rudko et al. Dec 2004 A1
20040260317 Bloom et al. Dec 2004 A1
20040260322 Rudko et al. Dec 2004 A1
20040260389 Case et al. Dec 2004 A1
20040260390 Sarac et al. Dec 2004 A1
20040260393 Rahdert et al. Dec 2004 A1
20040260394 Douk et al. Dec 2004 A1
20040267357 Allen et al. Dec 2004 A1
20050004583 Oz et al. Jan 2005 A1
20050004667 Swinford et al. Jan 2005 A1
20050010285 Lambrecht Jan 2005 A1
20050010287 Macoviak et al. Jan 2005 A1
20050015112 Cohn Jan 2005 A1
20050021056 St. Goar et al. Jan 2005 A1
20050021136 Xie et al. Jan 2005 A1
20050027261 Weaver et al. Feb 2005 A1
20050027348 Case et al. Feb 2005 A1
20050027351 Reuter et al. Feb 2005 A1
20050027353 Alferness et al. Feb 2005 A1
20050033398 Seguin Feb 2005 A1
20050033419 Alferness et al. Feb 2005 A1
20050033446 Deem et al. Feb 2005 A1
20050038506 Webler et al. Feb 2005 A1
20050038507 Alferness et al. Feb 2005 A1
20050043790 Seguin Feb 2005 A1
20050043792 Solem et al. Feb 2005 A1
20050049679 Taylor et al. Mar 2005 A1
20050049692 Numamoto et al. Mar 2005 A1
20050049696 Siess et al. Mar 2005 A1
20050049697 Sievers Mar 2005 A1
20050054977 Laird et al. Mar 2005 A1
20050055079 Duran Mar 2005 A1
20050055087 Starksen Mar 2005 A1
20050055088 Liddicoat et al. Mar 2005 A1
20050055089 Macoviak et al. Mar 2005 A1
20050060029 Le et al. Mar 2005 A1
20050060030 Lashinski et al. Mar 2005 A1
20050065460 Laird Mar 2005 A1
20050065550 Starksen et al. Mar 2005 A1
20050065594 Dimatteo et al. Mar 2005 A1
20050065597 Lansac Mar 2005 A1
20050070998 Rourke et al. Mar 2005 A1
20050075584 Cali Apr 2005 A1
20050075659 Realyvasquez et al. Apr 2005 A1
20050075662 Pedersen Apr 2005 A1
20050075712 Biancucci et al. Apr 2005 A1
20050075713 Biancucci et al. Apr 2005 A1
20050075717 Nguyen et al. Apr 2005 A1
20050075718 Nguyen et al. Apr 2005 A1
20050075719 Bergheim Apr 2005 A1
20050075720 Nguyen et al. Apr 2005 A1
20050075723 Schroeder et al. Apr 2005 A1
20050075724 Svanidze et al. Apr 2005 A1
20050075725 Rowe Apr 2005 A1
20050075726 Svanidze et al. Apr 2005 A1
20050075728 Nguyen et al. Apr 2005 A1
20050075729 Nguyen et al. Apr 2005 A1
20050075730 Myers et al. Apr 2005 A1
20050075731 Artof et al. Apr 2005 A1
20050080483 Solem et al. Apr 2005 A1
20050085900 Case et al. Apr 2005 A1
20050085903 Lau Apr 2005 A1
20050085904 Lemmon Apr 2005 A1
20050090846 Pedersen et al. Apr 2005 A1
20050096735 Hojeibane et al. May 2005 A1
20050096738 Cali et al. May 2005 A1
20050096739 Cao May 2005 A1
20050096740 Langberg et al. May 2005 A1
20050101975 Nguyen et al. May 2005 A1
20050102026 Turner et al. May 2005 A1
20050107810 Morales et al. May 2005 A1
20050107811 Starksen et al. May 2005 A1
20050107812 Starksen et al. May 2005 A1
20050107872 Mensah et al. May 2005 A1
20050113910 Paniagua et al. May 2005 A1
20050119673 Gordon et al. Jun 2005 A1
20050119734 Spence et al. Jun 2005 A1
20050119735 Spence et al. Jun 2005 A1
20050125011 Spence et al. Jun 2005 A1
20050131438 Cohn Jun 2005 A1
20050137449 Nieminen et al. Jun 2005 A1
20050137450 Aronson et al. Jun 2005 A1
20050137451 Gordon et al. Jun 2005 A1
20050137676 Richardson Jun 2005 A1
20050137681 Shoemaker et al. Jun 2005 A1
20050137682 Justino Jun 2005 A1
20050137685 Nieminen et al. Jun 2005 A1
20050137686 Salahieh Jun 2005 A1
20050137688 Salahieh Jun 2005 A1
20050137689 Salahieh Jun 2005 A1
20050137690 Salahieh Jun 2005 A1
20050137691 Salahieh Jun 2005 A1
20050137692 Haug et al. Jun 2005 A1
20050137693 Haug et al. Jun 2005 A1
20050137694 Haug et al. Jun 2005 A1
20050137696 Salahieh Jun 2005 A1
20050137697 Salahieh Jun 2005 A1
20050137698 Salahieh Jun 2005 A1
20050137699 Salahieh et al. Jun 2005 A1
20050137700 Spence et al. Jun 2005 A1
20050137701 Salahieh Jun 2005 A1
20050137702 Haug et al. Jun 2005 A1
20050143807 Pavcnik et al. Jun 2005 A1
20050143809 Salahieh et al. Jun 2005 A1
20050143810 Dauner et al. Jun 2005 A1
20050143811 Realyvasquez Jun 2005 A1
20050149014 Hauck et al. Jul 2005 A1
20050149179 Mathis et al. Jul 2005 A1
20050149180 Mathis et al. Jul 2005 A1
20050149181 Eberhardt Jul 2005 A1
20050159810 Filsoufi Jul 2005 A1
20050159811 Lane Jul 2005 A1
20050165477 Anduiza et al. Jul 2005 A1
20050165478 Song Jul 2005 A1
20050171472 Lutter Aug 2005 A1
20050171601 Cosgrove et al. Aug 2005 A1
20050177227 Heim et al. Aug 2005 A1
20050177228 Solem et al. Aug 2005 A1
20050182483 Osborne et al. Aug 2005 A1
20050184122 Hlavka et al. Aug 2005 A1
20050187614 Agnew Aug 2005 A1
20050187616 Realyvasquez Aug 2005 A1
20050187617 Navia Aug 2005 A1
20050192606 Paul, Jr. et al. Sep 2005 A1
20050192665 Spenser et al. Sep 2005 A1
20050197692 Pai et al. Sep 2005 A1
20050197693 Pai et al. Sep 2005 A1
20050197694 Pai et al. Sep 2005 A1
20050203549 Realyvasquez Sep 2005 A1
20050203605 Dolan Sep 2005 A1
20050203614 Forster et al. Sep 2005 A1
20050203615 Forster et al. Sep 2005 A1
20050203616 Cribier Sep 2005 A1
20050203617 Forster et al. Sep 2005 A1
20050203618 Sharkawy et al. Sep 2005 A1
20050216039 Lederman Sep 2005 A1
20050216077 Mathis et al. Sep 2005 A1
20050216078 Starksen et al. Sep 2005 A1
20050222675 Sauter Oct 2005 A1
20050222678 Lashinski et al. Oct 2005 A1
20050228422 Machold et al. Oct 2005 A1
20050228479 Pavcnik et al. Oct 2005 A1
20050228486 Case et al. Oct 2005 A1
20050228494 Marquez Oct 2005 A1
20050228495 Macoviak Oct 2005 A1
20050228496 Mensah et al. Oct 2005 A1
20050234541 Hunt et al. Oct 2005 A1
20050234546 Nugent et al. Oct 2005 A1
20050240200 Bergheim Oct 2005 A1
20050240202 Shennib et al. Oct 2005 A1
20050240255 Schaeffer Oct 2005 A1
20050240259 Sisken et al. Oct 2005 A1
20050240262 White Oct 2005 A1
20050244460 Alferiev et al. Nov 2005 A1
20050246013 Gabbay Nov 2005 A1
20050251251 Cribier Nov 2005 A1
20050256566 Gabbay Nov 2005 A1
20050261704 Mathis Nov 2005 A1
20050261759 Lambrecht et al. Nov 2005 A1
20050267493 Schreck et al. Dec 2005 A1
20050267560 Bates Dec 2005 A1
20050267565 Dave et al. Dec 2005 A1
20050267571 Spence et al. Dec 2005 A1
20050267573 Macoviak et al. Dec 2005 A9
20050267574 Cohn et al. Dec 2005 A1
20050272969 Alferness et al. Dec 2005 A1
20050273160 Lashinski et al. Dec 2005 A1
20050278015 Dave et al. Dec 2005 A1
20050283178 Flagle et al. Dec 2005 A1
20050288779 Shaoulian et al. Dec 2005 A1
20060000715 Whitcher et al. Jan 2006 A1
20060004439 Spenser et al. Jan 2006 A1
20060004442 Spenser et al. Jan 2006 A1
20060009804 Pederson Jan 2006 A1
20060009841 McGuckin, Jr. et al. Jan 2006 A1
20060009842 Huynh et al. Jan 2006 A1
20060013805 Hebbel et al. Jan 2006 A1
20060013855 Carpenter et al. Jan 2006 A1
20060015136 Besselink Jan 2006 A1
20060015178 Moaddeb et al. Jan 2006 A1
20060015179 Bulman-Fleming et al. Jan 2006 A1
20060020275 Goldfarb et al. Jan 2006 A1
20060020327 Lashinski et al. Jan 2006 A1
20060020332 Lashinski et al. Jan 2006 A1
20060020334 Lashinski et al. Jan 2006 A1
20060020335 Kowalsky et al. Jan 2006 A1
20060020336 Liddicoat Jan 2006 A1
20060025750 Starksen et al. Feb 2006 A1
20060025784 Starksen et al. Feb 2006 A1
20060025787 Morales et al. Feb 2006 A1
20060025854 Lashinski et al. Feb 2006 A1
20060025855 Lashinski et al. Feb 2006 A1
20060025856 Ryan et al. Feb 2006 A1
20060025857 Bergheim et al. Feb 2006 A1
20060030747 Kantrowitz et al. Feb 2006 A1
20060030866 Schreck Feb 2006 A1
20060030882 Adams et al. Feb 2006 A1
20060030885 Hyde Feb 2006 A1
20060036317 Vidlund et al. Feb 2006 A1
20060041305 Lauterjung Feb 2006 A1
20060041306 Vidlund et al. Feb 2006 A1
20060047297 Case Mar 2006 A1
20060047338 Jenson Mar 2006 A1
20060047343 Oviatt et al. Mar 2006 A1
20060052804 Mialhe Mar 2006 A1
20060052867 Revuelta et al. Mar 2006 A1
20060058817 Starksen et al. Mar 2006 A1
20060058865 Case et al. Mar 2006 A1
20060058871 Zakay et al. Mar 2006 A1
20060058889 Case et al. Mar 2006 A1
20060064115 Allen et al. Mar 2006 A1
20060064116 Allen et al. Mar 2006 A1
20060064118 Kimblad Mar 2006 A1
20060064174 Zadno Mar 2006 A1
20060069400 Burnett et al. Mar 2006 A1
20060069429 Spence et al. Mar 2006 A1
20060069430 Rahdert et al. Mar 2006 A9
20060074483 Schrayer Apr 2006 A1
20060074484 Huber Apr 2006 A1
20060074485 Realyvasquez Apr 2006 A1
20060085060 Campbell Apr 2006 A1
20060089708 Osse et al. Apr 2006 A1
20060095115 Bladillah et al. May 2006 A1
20060095125 Chinn et al. May 2006 A1
20060099326 Keogh et al. May 2006 A1
20060100697 Casanova May 2006 A1
20060100699 Vidlund et al. May 2006 A1
20060106278 Machold et al. May 2006 A1
20060106279 Machold et al. May 2006 A1
20060111660 Wolf et al. May 2006 A1
20060111773 Rittgers et al. May 2006 A1
20060111774 Samkov et al. May 2006 A1
20060116572 Case Jun 2006 A1
20060116756 Solem et al. Jun 2006 A1
20060122686 Gilad et al. Jun 2006 A1
20060122692 Gilad et al. Jun 2006 A1
20060122693 Biadillah et al. Jun 2006 A1
20060127443 Helmus Jun 2006 A1
20060129235 Seguin et al. Jun 2006 A1
20060129236 McCarthy Jun 2006 A1
20060135476 Kutryk et al. Jun 2006 A1
20060135964 Vesely Jun 2006 A1
20060135967 Realyvasquez Jun 2006 A1
20060136044 Osborne Jun 2006 A1
20060136045 Flagle et al. Jun 2006 A1
20060136052 Vesely Jun 2006 A1
20060136054 Berg et al. Jun 2006 A1
20060142846 Pavcnik et al. Jun 2006 A1
20060142847 Shaknovich Jun 2006 A1
20060142848 Gabbay Jun 2006 A1
20060142854 Alferness et al. Jun 2006 A1
20060149358 Zilla et al. Jul 2006 A1
20060149360 Schwammenthal et al. Jul 2006 A1
20060149367 Sieracki Jul 2006 A1
20060149368 Spence Jul 2006 A1
20060161133 Laird et al. Jul 2006 A1
20060161248 Case et al. Jul 2006 A1
20060161249 Realyvasquez et al. Jul 2006 A1
20060161250 Shaw Jul 2006 A1
20060167468 Gabbay Jul 2006 A1
20060167541 Lattouf Jul 2006 A1
20060167542 Quintessenza Jul 2006 A1
20060167543 Bailey et al. Jul 2006 A1
20060173490 Lafontaine Aug 2006 A1
20080269877 Jenson Oct 2008 A1
20100131056 Lapeyre May 2010 A1
Foreign Referenced Citations (167)
Number Date Country
0380666 Aug 1990 EP
0466518 Jan 1992 EP
2728457 Jun 1996 FR
8800459 Jan 1988 WO
9015582 Dec 1990 WO
9501669 Jan 1995 WO
9619159 Jun 1996 WO
9803656 Jan 1998 WO
9846115 Oct 1998 WO
9904724 Feb 1999 WO
0067679 Nov 2000 WO
0115650 Mar 2001 WO
0117462 Mar 2001 WO
03047468 Jun 2003 WO
03008443 Oct 2003 WO
2004019825 Mar 2004 WO
2004021893 Mar 2004 WO
2004023980 Mar 2004 WO
2004030568 Apr 2004 WO
2004030569 Apr 2004 WO
2004030570 Apr 2004 WO
2004032724 Apr 2004 WO
2004032796 Apr 2004 WO
2004037128 May 2004 WO
2004037317 May 2004 WO
2004039432 May 2004 WO
2004043265 May 2004 WO
2004043273 May 2004 WO
2004043293 May 2004 WO
2004045370 Jun 2004 WO
2004045378 Jun 2004 WO
2004045463 Jun 2004 WO
2004047677 Jun 2004 WO
2004060217 Jul 2004 WO
2004060470 Jul 2004 WO
2004062725 Jul 2004 WO
2004066803 Aug 2004 WO
2004066826 Aug 2004 WO
2004069287 Aug 2004 WO
2004075789 Sep 2004 WO
2004080352 Sep 2004 WO
2004082523 Sep 2004 WO
2004082527 Sep 2004 WO
2004082528 Sep 2004 WO
2004082536 Sep 2004 WO
2004082537 Sep 2004 WO
2004082538 Sep 2004 WO
2004082757 Sep 2004 WO
2004084746 Oct 2004 WO
2004084770 Oct 2004 WO
2004089246 Oct 2004 WO
2004089250 Oct 2004 WO
2004089253 Oct 2004 WO
2004091449 Oct 2004 WO
2004091454 Oct 2004 WO
2004093638 Nov 2004 WO
2004093726 Nov 2004 WO
2004093728 Nov 2004 WO
2004093730 Nov 2004 WO
2004093745 Nov 2004 WO
2004093935 Nov 2004 WO
2004096100 Nov 2004 WO
2004103222 Dec 2004 WO
2004103223 Dec 2004 WO
2004105584 Dec 2004 WO
2004105651 Dec 2004 WO
2004112582 Dec 2004 WO
2004112585 Dec 2004 WO
2004112643 Dec 2004 WO
2004112652 Dec 2004 WO
2004112657 Dec 2004 WO
2004112658 Dec 2004 WO
2005000152 Jan 2005 WO
2005002424 Jan 2005 WO
2005002466 Jan 2005 WO
2005004753 Jan 2005 WO
2005007017 Jan 2005 WO
2005007018 Jan 2005 WO
2005007036 Jan 2005 WO
2005007037 Jan 2005 WO
2005009285 Feb 2005 WO
2005009286 Feb 2005 WO
2005009505 Feb 2005 WO
2005009506 Feb 2005 WO
2005011473 Feb 2005 WO
2005011534 Feb 2005 WO
2005011535 Feb 2005 WO
2005013860 Feb 2005 WO
2005018507 Mar 2005 WO
2005021063 Mar 2005 WO
2005023155 Mar 2005 WO
2005025644 Mar 2005 WO
2005027790 Mar 2005 WO
2005027797 Mar 2005 WO
2005034812 Apr 2005 WO
2005039428 May 2005 WO
2005039452 May 2005 WO
2005046488 May 2005 WO
2005046528 May 2005 WO
2005046529 May 2005 WO
2005046530 May 2005 WO
2005046531 May 2005 WO
2005048883 Jun 2005 WO
2005049103 Jun 2005 WO
2005051226 Jun 2005 WO
2005055811 Jun 2005 WO
2005055883 Jun 2005 WO
2005058206 Jun 2005 WO
2005065585 Jul 2005 WO
2005065593 Jul 2005 WO
2005065594 Jul 2005 WO
2005070342 Aug 2005 WO
2005070343 Aug 2005 WO
2005072654 Aug 2005 WO
2005072655 Aug 2005 WO
2005079706 Sep 2005 WO
2005082288 Sep 2005 WO
2005082289 Sep 2005 WO
2005084595 Sep 2005 WO
2005087139 Sep 2005 WO
2005087140 Sep 2005 WO
2006000763 Jan 2006 WO
2006000776 Jan 2006 WO
2006002492 Jan 2006 WO
2006004679 Jan 2006 WO
2006005015 Jan 2006 WO
2006009690 Jan 2006 WO
2006011127 Feb 2006 WO
2006012011 Feb 2006 WO
2006012013 Feb 2006 WO
2006012038 Feb 2006 WO
2006012068 Feb 2006 WO
2006012322 Feb 2006 WO
2006019498 Feb 2006 WO
2006026371 Mar 2006 WO
2006026377 Mar 2006 WO
2006026912 Mar 2006 WO
2006027499 Mar 2006 WO
2006028821 Mar 2006 WO
2006029062 Mar 2006 WO
2006031436 Mar 2006 WO
2006031469 Mar 2006 WO
2006032051 Mar 2006 WO
2006034245 Mar 2006 WO
2006035415 Apr 2006 WO
2006041505 Apr 2006 WO
2006044679 Apr 2006 WO
2006048664 May 2006 WO
2006050459 May 2006 WO
2006050460 May 2006 WO
2006054107 May 2006 WO
2006054930 May 2006 WO
2006055982 May 2006 WO
2006060546 Jun 2006 WO
2006063108 Jun 2006 WO
2006063181 Jun 2006 WO
2006063199 Jun 2006 WO
2006064490 Jun 2006 WO
2006065212 Jun 2006 WO
2006065930 Jun 2006 WO
2006066148 Jun 2006 WO
2006066150 Jun 2006 WO
2006069094 Jun 2006 WO
2006070372 Jul 2006 WO
2006073628 Jul 2006 WO
2006076890 Jul 2006 WO
20060149360 Jul 2006 WO
Non-Patent Literature Citations (5)
Entry
US 6,673,110, 01/2004, Alfieri et al. (withdrawn)
US 6,723,117, 04/2004, Menz et al. (withdrawn)
All non-patent literature documents and foreign patent documents have been previously uploaded in parent U.S. Appl. No. 11/049,019, filed Feb. 18, 2005.
European Office Action in related European Patent Application No. 06 717 435.9. Jul. 26, 2010. 6 pages.
All non-patent literature documents and foreign patent documents have been previously uploaded in U.S. Appl. No. parent 11/049,019, filed Feb. 18, 2005.
Related Publications (1)
Number Date Country
20150142102 A1 May 2015 US
Continuations (1)
Number Date Country
Parent 11049019 Feb 2005 US
Child 14604125 US